Höfundar: Ólafur Árni Sveinsson

Long-term use of rituximab increases T cell count in MS patients

Long-term use of rituximab increases T cell count in MS patients

Prevalence of myotonic dystrophy type 1 in Iceland is three times the world average with 77% of cases identified through indirect family-mediated cascade testing

Scroll to Top

Á þessu vefsvæði eru notaðar vafrakökur.